Coronary artery disease is a common, serious and insidious complication of
diabetes. Myocardial ischaemia is often silent. All diabetics do not have t
he same coronary risk and, therefore, it is important to determine which in
vestigations to perform and which patients.
This strategy is justified because it allows identification of these cases
which require a medical or an invasive (angioplasty, surgical revascularisa
tion) approach, as these interventions may improve the prognosis. The first
stage is clinical (investigation of cardiovascular risk factors). When mor
e than two risk factors are found, further investigations are justified.
Exercise stress testing provide reassuring diagnostic and prognostic data w
hen maximal and negative. When sub-maximal, impossible or significantly isc
haemic, a second investigation is useful. Holter ECG recording with analysi
s of ST Variation lacks sensitivity and, above all, specificity. The diagno
stic value of perfusion myocardial scintigraphy in the diabetic is not as g
ood as that observed in the general population, but its prognostic value re
mains good. Ischaemia involving over 20 % of the myocardium justifies thera
peutic investigation. Stress echocardiography has been validated in the dia
gnosis and prognosis of coronary artery disease and its sensitivity and spe
cificity are probably the same as those of scintigraphy.
The authors conclude that the asymptomatic diabetic requires clinical and s
taged paraclinical investigation to assess prognosis and, depending on the
results, the adoption of a beneficial therapeutic strategy.